Trial intelligence / Profile preview

Sirolimus for mild proteinuric flares in lupus nephritis

NCT04892212Phase 3Unknown

Sponsor
Peking Union Medical College Hospital
Start
Jun 2021
Primary completion
Jun 2023
Modality
Small Molecules
01

Overview

A Phase 3 trial of sirolimus in lupus nephritis (LN), sponsored by Peking Union Medical College Hospital. Status: unknown.

02

Drugs

sirolimus
03

Conditions

lupus nephritis (LN)

Beyond the preview

Go deeper on NCT04892212.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04892212.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call